Matthew Kaplan analyst

Currently out of the existing stock ratings of Matthew Kaplan, 76 are a BUY (93.83%), 5 are a HOLD (6.17%).

Matthew Kaplan

Work Performance Price Targets & Ratings Chart

Analyst Matthew Kaplan, has had 48.56% of price targets met with an average potential upside of 83.94%, reached in 237 days on average. Previously, Matthew Kaplan worked at LADENBURG.

Matthew Kaplan has documented 154 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on UTHR, United Therapeutics at 31-Oct-2024.

Wall Street Analyst Matthew Kaplan

Analyst best performing recommendations are on AXSM (AXSOME THERAPEUTICS).
The best stock recommendation documented was for AXSM (AXSOME THERAPEUTICS) on 10/17/2018. The price target of $34 was fulfilled within 400 days with a profit of $30.08 (767.35%), with a performance score of 19.18.

Average potential price target upside

ARDX Ardelyx AXSM Axsome Therapeutics LPCN Lipocine MLND Millendo Therapeutics RETA Reata Pharmaceuticals TGTX TG Therapeutics UTHR United Therapeutics ALNA Allena Pharmaceuticals BDSI BioDelivery Sciences International RPHM Reneo Pharmaceuticals STML Stemline Therapeutics URGN UroGen Pharma Ltd AVDL Avadel Pharmaceuticals PLC IMUX Immunic LQDA Liquidia Technologies TARA Protara Therapeutics ATNX Athenex PSTI Pluristem RCOR Renovacor

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Apr-2023

$9

$5.91 (191.26%)

$19

3 months 1 days ago
(18-Aug-2026)

7/20 (35%)

$5.08 (129.59%)

247

Buy Since 26-Sep-2025

$15

$11.91 (385.44%)

$19

3 months 2 days ago
(17-Aug-2026)

14/24 (58.33%)

$10.94 (269.46%)

437

Buy Since 03-Mar-2016

$11

$7.91 (255.99%)

$14

3 months 9 days ago
(10-Aug-2026)

8/17 (47.06%)

$7 (175.00%)

307

Buy Since 04-Mar-2025

$14

$10.91 (353.07%)

$17

3 months 12 days ago
(07-Aug-2026)

0/7 (0%)

$10 (250.00%)

Buy Since 03-May-2024

$10

$6.91 (223.62%)

$10

3 months 12 days ago
(07-Aug-2026)

0/4 (0%)

$6 (150.00%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?